<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01705522</url>
  </required_header>
  <id_info>
    <org_study_id>COL-GASTRO-3</org_study_id>
    <nct_id>NCT01705522</nct_id>
  </id_info>
  <brief_title>Multimodal Approach in IBD Patients</brief_title>
  <acronym>MAID</acronym>
  <official_title>Multimodal Approach in IBD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Colentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Hospital Colentina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators intend to assess the role of several biomarkers in the prediction of
      relapse in IBD. Clinical, laboratory and endoscopic data will be gathered and a predictive
      score will be derived in order to assess the relapse risk at 1 year.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with a confirmed diagnosis of IBD will be prospectively assessed on a yearly basis
      in order to assess relapse risk factors.

      Disease activity will be assessed using the Mayo score for UC patients and CDAI for Crohn's
      disease and endoscopic activity will be assessed using the Mayo endoscopic subscore for UC
      patients and the Simple Endoscopic Score for Crohn's Disease for CD patients.

      Serum and fecal biomarkers will be obtainted at each study visit (C-reactive protein, fecal
      calprotectin).

      Data about current and past medication for IBD will also be gathered.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical relapse</measure>
    <time_frame>1 year</time_frame>
    <description>clinical relapse as assessed by conventional scores for activity in IBD - Mayo or CDAI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of NAFLD</measure>
    <time_frame>1 year</time_frame>
    <description>to assess the prevalence of nonalcoholic liver disease in IBD patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>prevalence of vitamin D deficiency</measure>
    <time_frame>1 year</time_frame>
    <description>to assess vitamin D deficiency and osteopenia among IBD patients</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn's Disease</condition>
  <condition>Nonalcoholic Fatty Liver Disease (NAFLD)</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>IBD patients</arm_group_label>
    <description>patients with ulcerative colitis or crohn's disease, in remission</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and fecal samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with IBD over 18 years of age, currently in clinical remission
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ulcerative colitis or Crohn's disease

          -  age over 18

          -  clinical remission

          -  signed informed consent

        Exclusion Criteria:

          -  pregnant women

          -  refusal to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodor Voiosu, Md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Colentina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Theodor A Voiosu, MD</last_name>
    <phone>0040726732764</phone>
    <email>theodor.voiosu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Colentina Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreea Bengus, MD</last_name>
      <phone>0040744497626</phone>
      <email>andreeabengus@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Theodor A Voiosu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Dionne S, Hiscott J, D'Agata I, Duhaime A, Seidman EG. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci. 1997 Jul;42(7):1557-66.</citation>
    <PMID>9246063</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2012</study_first_submitted>
  <study_first_submitted_qc>October 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2012</study_first_posted>
  <last_update_submitted>October 22, 2017</last_update_submitted>
  <last_update_submitted_qc>October 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Colentina</investigator_affiliation>
    <investigator_full_name>dr. Theodor Alexandru Voiosu</investigator_full_name>
    <investigator_title>Gastroenterology resident, Teaching Assistant</investigator_title>
  </responsible_party>
  <keyword>IBD</keyword>
  <keyword>ulcerative colitis</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>NAFLD</keyword>
  <keyword>biomarkers</keyword>
  <keyword>vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

